Effects of Enterococcus sp. isolated from deep seawater on inhibition of allergic responses in mice

The objective of the present study was to assess the effects of Enterococcus sp. strain TN-3 isolated from deep seawater on inhibition of eosinophil accumulation, IgE production and active cutaneous anaphylaxis (ACA). We investigated the effects of viable and non-viable TN-3 on allergen-induced peri...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of nutrition Vol. 102; no. 1; pp. 3 - 7
Main Authors Kondoh, Masatoshi, Hayashi, Atsushi, Okamori, Mariko, Motonaga, Chie, Enomoto, Tadao, Cheng, Lei, Shimada, Takashi
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 14.07.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The objective of the present study was to assess the effects of Enterococcus sp. strain TN-3 isolated from deep seawater on inhibition of eosinophil accumulation, IgE production and active cutaneous anaphylaxis (ACA). We investigated the effects of viable and non-viable TN-3 on allergen-induced peritoneal eosinophil accumulation in mice. Viable (5·4 × 1010 colony-forming units per 60 mg) or non-viable TN-3 (60 mg) was orally administered to BALB/c mice that had been sensitised with the cedar pollen (Cryptomeria japonica) allergen. Oral administration of non-viable TN-3 was effective in suppressing eosinophil accumulation while viable TN-3 was ineffective. We also examined the dose–response relationship for non-viable TN-3 in regard to eosinophil accumulation, IgE production and ACA in allergen-primed mice. Non-viable TN-3 was orally administered at doses of 15 mg (low dose), 30 mg (medium dose) and 60 mg (high dose) to BALB/c mice that had been sensitised with cedar pollen allergen. The anti-allergic effects expressed as inhibition of eosinophil accumulation, IgE production and ACA were found at the low and high doses, but not at the medium dose. These results suggest that non-viable TN-3 exhibited anti-allergic effects at doses of 15 and 60 mg.
Bibliography:http://dx.doi.org/10.1017/S0007114508158998
Abbreviations: ACA, active cutaneous anaphylaxis; LAB, lactic acid bacteria
PII:S0007114508158998
istex:920BE00A29EC7711E7850311884D1A101BDD22D3
ark:/67375/6GQ-1LRBD629-L
ArticleID:15899
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0007-1145
1475-2662
DOI:10.1017/S0007114508158998